United States · Health Care startup
United States · Magnus Medical
Magnus Medical develops a closed-loop neuromodulation technology to effectively treat intractable neurological and psychiatric disorders.
Funding reportedLast round: Series A
Follow Magnus Medical and see its new rounds in your feed.Start following
What company datasets say Magnus Medical raised
Funding, as reported
Reported in all$64Min dollars
Rounds1
Last roundSeries A
Last round dateOct 2021
Investors listed2
SEC Form D$113M sold, 3 filings, last May 2026
Founders and team
From Magnus Medical's own website: 7 on the team.
- Achal Singh AchrolChief Executive Officer
- David DangVice President of Finance
- Dee KolanekVice President of Market Access & Reimbursement
- Huyen DuongVice President of Clinical, Quality and Regulatory
- Matt WallaceVice President of Sales
- Romain Moreau-GobardSenior Vice President of Technology
- Trevor KeatingVice President of Marketing
On 2 portfolio pages
Investors who name them
Each firm lists Magnus Medical on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Health Care in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Magnus Medical in front of investors. Or tell us what we have wrong.